Banerjee Subhashis 4
4 · Artiva Biotherapeutics, Inc. · Filed Apr 25, 2025
Insider Transaction Report
Form 4
Banerjee Subhashis
Chief Medical Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2025-04-08+80,000→ 80,000 totalExercise: $1.92Exp: 2035-04-07→ Common Stock (80,000 underlying) - Award
Common Stock
2025-04-08+50,000→ 50,000 total
Footnotes (2)
- [F1]Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan.
- [F2]25% of the shares initially subject to the option will vest and become exercisable on April 8, 2026, and the balance of the shares subject to the option shall vest and become exercisable at a rate of 1/36th per month over the following 36 months.